Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SGMO | AMGN | BMY | VRTX | GILD |
| Company | Sangamo Therapeutics | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.9500 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 1.9700 | 288.83 | 58.22 | 455.43 | 89.07 |
| Low | 1.8900 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 1.9400 | 289.40 | 58.03 | 448.30 | 89.02 |
| Change | -0.0100 | +1.53 | +0.15 | -2.93 | +0.39 |
| % Change | -0.51% | +0.53% | +0.26% | -0.65% | +0.44% |
| Volume | 893,151 | 570,023 | 1,596,943 | 263,583 | 789,778 |
| 20-Day Average Volume | 10,336,715 | 2,769,439 | 12,097,357 | 1,281,661 | 7,360,405 |
| Previous Close | 1.9500 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.1465 | 307.25 | 55.90 | 479.10 | 90.84 |
| 20-Day Raw Stochastic | 32.10% | 20.95% | 65.21% | 3.33% | 21.06% |
| 20-Day Relative Strength | 54.06% | 34.30% | 59.84% | 40.14% | 51.39% |
| Weighted Alpha | -26.66 | +0.33 | +24.94 | +17.05 | +24.17 |
| Today's Opinion | 88% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 88% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 100% Buy | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.16% since 11/14/24 | -3.15% since 11/14/24 | -1.10% since 11/14/24 | -7.51% since 11/14/24 | -3.62% since 11/14/24 |
| Low | 1.8200 on 11/18/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 2.1850 on 11/15/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | +109.20% since 10/21/24 | -9.52% since 10/21/24 | +11.00% since 10/21/24 | -6.37% since 10/21/24 | +2.89% since 10/21/24 |
| Low | 1.1500 on 10/22/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 3.1790 on 11/08/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +118.29% since 08/21/24 | -12.93% since 08/21/24 | +19.44% since 08/21/24 | -7.92% since 08/21/24 | +18.17% since 08/21/24 |
| Low | 0.7000 on 09/09/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 3.1790 on 11/08/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +219.72% since 05/21/24 | -8.97% since 05/21/24 | +36.87% since 05/21/24 | +1.27% since 05/21/24 | +31.94% since 05/21/24 |
| Low | 0.3040 on 07/05/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 3.1790 on 11/08/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 406,862 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 208,647 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 176,230,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -257,830,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 49,410,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | 10,670,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.10 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.04 on 11/12/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/12/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |